Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
14.09.24 | J&J Announces Promising Phase 1b/2 Data For Amivantamab Combination In Metastatic Colorectal Cancer | 1.135 | AFX News | NEW BRUNSWICK (dpa-AFX) - Janssen-Cilag International NV, a Johnson & Johnson (JNJ) company, announced new data from the Phase 1b/2 OrigAMI-1 study, which showed amivantamab combined with chemotherapy... ► Artikel lesen | |
14.09.24 | DIRECTV Reaches Agreement To Restore Disney Networks And Streaming Services | 951 | AFX News | BURBANK (dpa-AFX) - DIRECTV and The Walt Disney Company have reached an agreement in principle for the distribution of Disney's linear networks and direct-to-consumer services, following a roughly... ► Artikel lesen | |
14.09.24 | Pfizer: Phase 2 Study Of Ponsegromab In Cancer Cachexia Meets Primary Endpoint | 1.277 | AFX News | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) said Saturday that its Phase 2 study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its primary... ► Artikel lesen | |
14.09.24 | Pfizer's BRAFTOVI + MEKTOVI Delivers Long-Term Benefits In BRAF V600E-Mutant NSCLC | 863 | AFX News | NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) announced longer-term follow-up results from the Phase 2 single-arm PHAROS clinical trial evaluating the efficacy and safety of BRAFTOVI (encorafenib)... ► Artikel lesen | |
14.09.24 | J&J: RYBREVANT + Chemotherapy Shows Strong Benefits And Improved Survival In Phase 3 NSCLC Trial | 758 | AFX News | NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced that updated results from the Phase 3 MARIPOSA-2 study showed that combining RYBREVANT (amivantamab-vmjw) with chemotherapy provided... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.034 |
NOVO NORDISK | 1.964 |
PUMA | 1.776 |
D-WAVE QUANTUM | 1.493 |
BAYER | 1.489 |
TUI | 1.468 |
EVOTEC | 1.464 |
DEUTSCHE BANK | 1.079 |
BASF | 1.013 |
RHEINMETALL | 944 |
VARTA | 914 |
NEL | 892 |
TESLA | 881 |
RENK GROUP | 852 |
PLUG POWER | 834 |
COMMERZBANK | 782 |
THYSSENKRUPP | 721 |
SIEMENS ENERGY | 689 |
MEDIGENE | 664 |
BIONTECH | 663 |
VOLKSWAGEN | 633 |
HEIDELBERGER DRUCK | 626 |
DEUTSCHE TELEKOM | 624 |
DEUTSCHE LUFTHANSA | 623 |
BYD | 611 |